Rangering i aksjer
#28557
PlexBio Co., Ltd. is dedicated to the creation and production of in vitro... PlexBio Co., Ltd. is dedicated to the creation and production of in vitro diagnostic (IVD) solutions for both molecular biology and immunology purposes. Their comprehensive product range features services for optimizing diagnostic workflows, as well as automated kits for sample preparation and extraction. A key innovation is their IntelliPlex platform, which leverages pCode technology to enable advanced, "sample-to-answer" multiplexing assays. The company also supplies specialized oncology panels designed for detecting lung cancer, gene mutations, and chromosomal rearrangements. Additionally, PlexBio offers a variety of infectious disease tests, including IntelliPlex kits for SARS-CoV-2 detection, influenza, and SARS-CoV-2 variant analysis, complemented by essential reagents such as pCode coupling buffer sets. Founded in 2009, PlexBio Co., Ltd. operates from its headquarters in Taipei, Taiwan.
Handel PlexBio Co., Ltd. (6572)
Pris 6572 pris med markedsverdi på B
Markedsverdi av PlexBio Co., Ltd.(6572)
Markedsverdi: $25.81M
Per August 2026 har PlexBio Co., Ltd. en markedsverdi på $25.81M. Dette gjør PlexBio Co., Ltd. til det 28557th mest verdifulle selskapet i verden basert på markedsverdi ifølge våre data. Markedsverdi er den totale markedsverdien av et børsnotert selskaps utestående aksjer og brukes vanligvis til å måle hvor mye et selskap er verdt.
Markedsverdihistorikk for PlexBio Co., Ltd. fra 2016 til 2026
6572 sammenlignet med topp 5 mest populære stocks
| Pris på 6572 |
|
Eiendel B |
Markedsverdi for B |
Resultater |
|
|
|
|
$5.301T
|
+20,538,841.25%
|
|
|
|
|
$4.634T
|
+17,954,458.51%
|
|
|
|
|
$4.143T
|
+16,052,448.24%
|
|
|
|
|
$3.589T
|
+13,907,417.87%
|
|
|
|
|
$2.857T
|
+11,069,539.98%
|
